Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary

por Szabó, Dora, Szentandrássy, Julia, Juhász, Zsuzsa, Katona, Katalin, Nagy, Károly, Rókusz, László
Publicado 2008

New therapeutic options for HCV in Central Europe

por Flisiak, Robert, Urbánek, Petr, Rokusz, Laszlo, Oltman, Marian, Makara, Mihaly, Janicko, Martin
Publicado 2016

Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)

por Kuzman, Ilija, Bezlepko, Alexandr, Kondova Topuzovska, Irena, Rókusz, László, Iudina, Liudmyla, Marschall, Hans-Peter, Petri, Thomas
Publicado 2014

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy

por Hunyady, Béla, Abonyi, Margit, Gerlei, Zsuzsanna, Gervain, Judit, Horváth, Gábor, Jancsik, Viktor, Lengyel, Gabriella, Makkai, Erzsébet, Pár, Alajos, Péter, Zoltán, Pusztay, Margit, Ribiczey, Pál, Rókusz, László, Sarrazin, Christoph, Schneider, Ferenc, Susser, Simone, Szalay, Ferenc, Tornai, István, Tusnádi, Anna, Újhelyi, Eszter, Werling, Klára, Makara, Mihály
Publicado 2018